- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Fund Finance
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Leveraged Finance
- Mergers and Acquisitions (M&A)
- Middle East and Islamic Finance and Investment
- Private Equity
- Public Companies
- Real Estate
- Structured Finance and Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- Innovation Protection
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Antitrust
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Corporate and Securities Litigation
- E-Discovery
- Global Construction and Infrastructure Disputes
- Innovation Protection
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy Transition
- Energy
- Financial Services
- Food and Beverage
- Higher Education
- Life Sciences and Healthcare
- Technology
- Artificial Intelligence (AI) and Machine Learning
- Buy American
- Crisis Management
- Doing Business in Latin America
- Environmental Agenda
- Environmental, Social and Governance (ESG)
- Focus on Women's Health
- Russia/Ukraine
- Special Purpose Acquisition Companies (SPACs)
- Careers
- News & Insights
- About
- Languages
Insights 11 results
Client Alert
October 22, 2025
PTO Proposes New Rules for Institution of IPR Proceedings; Comments Due by December 2, 2025
Client Alert
September 23, 2025
USPTO Acting Director Stewart Clarifies PTAB Treatment of Other Proceedings
Client Alert
September 18, 2025
Maximizing The Term Of Patent Protection For Medical Devices
Client Alert
September 5, 2025
Live Long and Patent: Lessons from Captain Kirk’s Encounter with the PTAB
Client Alert
August 15, 2025
USPTO Acting Director Stewart Limits Use of General Knowledge in IPR Petitions
Client Alert
May 30, 2025
New Executive Orders Aim to Accelerate and Expand Development of U.S. Nuclear Energy
Client Alert
January 9, 2025
Texas, Utah and Small Modular Reactor ("SMR") Developer Launch Lawsuit Alleging "Unlawful" Regulatory Regime
Client Alert
November 27, 2024
End of Year Compliance Updates
Article · Source: Intellectual Property Strategist
June 1, 2024
Federal Circuit Overrules 'Rosen-Durling' Test for Design Patent Obviousness
Client Alert
May 23, 2024
Federal Circuit Overrules Rosen-Durling Test For Design Patent Obviousness
Article · Source: PTAB Bar Association Law Journal
February 8, 2019
Due Process in AIA Proceedings after SAS Institute Inc. v. Iancu